ERBB2 and breast cancer: Next, we verified the transcriptional activation of AKT1m using quantitative RT-PCR on three primary human breast tissues and nine breast cancers, including three ERα-positive, three HER2-positive/ERα-negative, and three triple-negative specimens (Figure 6).